ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

MARIO MIGLIARIO; L. Tommasi; L. Benzi; C. Mortellaro; V. Fusco

doi:10.23736/S0026-4970.18.04215-2

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

MARIO MIGLIARIO
, L. Tommasi
, L. Benzi
, C. Mortellaro
, V. Fusco

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

Original language	English
Pages (from-to)	17-18
Number of pages	2
Journal	Minerva Stomatologica
Volume	67
Issue number	3
DOIs	https://doi.org/10.23736/S0026-4970.18.04215-2
Publication status	Published - 1 Jan 2018

Keywords

Bisphosphonate-Associated Osteonecrosis of the Jaw
Humans
Jaw Diseases
Osteonecrosis
Pharmacovigilance

Access to Document

10.23736/S0026-4970.18.04215-2

Cite this

@article{84542fb5d80d4f7f8c50099dc4593766,

title = "ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018",

abstract = "This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.",

keywords = "Bisphosphonate-Associated Osteonecrosis of the Jaw, Humans, Jaw Diseases, Osteonecrosis, Pharmacovigilance, Bisphosphonate-Associated Osteonecrosis of the Jaw, Humans, Jaw Diseases, Osteonecrosis, Pharmacovigilance",

author = "MARIO MIGLIARIO and L. Tommasi and L. Benzi and C. Mortellaro and V. Fusco",

year = "2018",

month = jan,

day = "1",

doi = "10.23736/S0026-4970.18.04215-2",

language = "English",

volume = "67",

pages = "17--18",

journal = "Minerva Stomatologica",

issn = "0026-4970",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "3",

}

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018. / MIGLIARIO, MARIO; Tommasi, L.; Benzi, L. et al.
In: Minerva Stomatologica, Vol. 67, No. 3, 01.01.2018, p. 17-18.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

AU - MIGLIARIO, MARIO

AU - Tommasi, L.

AU - Benzi, L.

AU - Mortellaro, C.

AU - Fusco, V.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

AB - This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

KW - Bisphosphonate-Associated Osteonecrosis of the Jaw

KW - Humans

KW - Jaw Diseases

KW - Osteonecrosis

KW - Pharmacovigilance

KW - Bisphosphonate-Associated Osteonecrosis of the Jaw

KW - Humans

KW - Jaw Diseases

KW - Osteonecrosis

KW - Pharmacovigilance

UR - https://iris.uniupo.it/handle/11579/112152

U2 - 10.23736/S0026-4970.18.04215-2

DO - 10.23736/S0026-4970.18.04215-2

M3 - Article

SN - 0026-4970

VL - 67

SP - 17

EP - 18

JO - Minerva Stomatologica

JF - Minerva Stomatologica

IS - 3

ER -

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this